期刊文献+

缬沙坦对68例原发性高血压左室重构的影响 被引量:1

Effect of Valsartan on left ventricular remodeling in patients with essential Hypertension
下载PDF
导出
摘要 目的:研究缬沙坦治疗原发性高血压左室重构的影响。方法:原发性高血压(EH)经彩色多普勒超声心动图证实有左室肥厚患者68例,给予缬沙坦80mg/d或160mg/d,服药8个月监测血压并复查彩色多普勒超声心动图行自身对照。结果:EH患者治疗前后收缩压及舒张压显著降低(P〈0.01),左心室舒张末径(LVI Pd)、室间隔厚度(IVSTd)、左室后壁厚度(LVPWT)、左室重量指数(LVMI)显著下降(P〈0.01)。结论:缬沙坦有确切的降压效果,并可改变EH的左室重构。 Objective:To study the effect of Valsartan on left ventricular re modeling in patients with essential hypertension. Methods:Left ventricular hypertrophy was diagnosed by color Doppler echocardiography in 68 patients with essential hypertensive. All patients were treated with valsartan (80mg to 160 mg per day) for eight month. After treatment, patients' blood pressure and echocar- diography were compared with the original. Results: Patients' systolic pressure and diastolic pressure decreased (P 〈0.01). LVIPd, IVSTd, LVPWT and LVMI reduced (P 〈0.01). Conclusions: Valsartan was effective on hypertension and left ventricalar remodeling.
出处 《中国民康医学》 2009年第15期1791-1792,共2页 Medical Journal of Chinese People’s Health
关键词 缬沙坦 高血压 左室重构 Valsartarn Hypertension left ventrieular remodeling
  • 相关文献

参考文献3

二级参考文献24

  • 1[1]Baker KM.Booz GW.Dostal D E. Catdiac actions of angiotensin Ⅱ role of an intracardiacrenin -angiotensin systems[J]. Annu Rev Physiol. 1997. 54 :227L-241 L.
  • 2[2]Izumi Y.Kim S.Zhan Y.et al. Important role of angiotensin Ⅱ-mediated e-Jun NH(2 )-terminal kinese activation in cardiac hypertrophy is hypertensive rats [J]. Hypertension,2000,36(4) :511-516.
  • 3[3]Suzuki J, Matsubara H, Urakami M et al. Rat angiotensin Ⅱ(type 1A) receptor mRNA regulation and subtype expression in myocardial growth and hypertrophy [J]. Cire Res, 1993,73 ( 3 ) :439-447.
  • 4[4]Aceto JF.Baker KM. [SarI]angiotensin Ⅲ receptor-mediated stimulation of protein synthesis in chick heart cells[J]. Am J Physiol,1990.258(3 Pt 2) :H806-H813.
  • 5[5]Harada M,Itoh H,Nakagawa O,et al. Sigaificance of ventricular myocytes and nommyocytes interaction during cardiocyte hypertrophy:evideace for endothelin-1 as a paracrine hypertrophic factor from cardiac nonmyooytes [ J ]. Circulation.1997 ,96( 10 ) :3737-3744.
  • 6[6]Mazzolai L,Pedrazzini T,Nicoud F,et al. Increased cardiac angiotensin Ⅱ levels induce right and left ventricular hypertrophy in normotensive mice [ J ]. Hypoertension.2000,35 (4) :985-991.
  • 7[7]Harada K, Komuro I ,Zou Y ,et al. Aeute pressure overlond could induce hypertrophic responses in the heart of angiotensin Ⅱ type la kmockout mice[ J]. Cire Res, 1998,82 (7) :779-785.
  • 8[8]Kajstura J,Cigola E. Malhotra A. et al. Angiotensin Ⅱ induces apoposis of ventricularmyocytes in vitro[ J ]. J Mol Cell Cardiol, 1997,29( 3 ) :859-870.
  • 9[9]Pierzchalaki P.Reiss K,Cheng W,et al. p53 Induces myocyte apoptosis via the activation of therenin-angioteasin system[J]. Exp Cell Res, 1997.234 ( 1 ) :57-65.
  • 10[10]Leri A,Claudio PP, Li Q,et al. Stretch-mediated release of angiotensin Ⅱ induces myocyte apoptosis by activatin p53 that enhances the local rennin-angiotensin system and decreases the Bcl-2-to-Bax Protein ratio in the cell [ J ]. J Clin Invest, 1998, 101 (7) : 1326-1342.

共引文献11

同被引文献10

  • 1陈灏珠,林果力.实用内科学.第13版.北京:人民卫生出版社,2009.
  • 2杨国君.高血压降压达标的内涵[J].中华高血压杂志,2007,15(9):786-789. 被引量:12
  • 3Jonab BS, Frank P, Ingrain DD.Are symptoms of maxiety and depression riskfactorsfor hypertension.Arch Fam Med, 1997, 6(1):43.
  • 4Vasan RS, Beiser A, Seshadri S. et al. Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study.JAMA: the journal of the American Medical Association, 2002, 287 (8): 1003-1010.
  • 5Nelson M. Drug treatment of elevated blood pressure.Australian Prescriber, 2010, 33(4):108-112.
  • 6Law M, Wald N, Morris J.Lowering blood pressure to prevent myocardial infarction and stroke:a new preventive strategy.Health Technol Assess, 2003, 7(31): 1-94.
  • 7Shaw G. Prehypertension: Early-stage High Blood Pressure. WebMD. http://www, webmd, com/content/article/73/88927.htm.
  • 8Okonofua EC, Simpson KN, Jesri A, et al. Therapeutic inertia is an impediment to achieving the Healthy People 2010 blood pressure control goals. Hypertension, 2006, 47(3): 345-351.
  • 9尹萍.贝那普利与苯磺酸左旋氨氯地平联用方案治疗210例原发性高血压的临床疗效观察[J].中国现代药物应用,2013,7(22):125-126. 被引量:6
  • 10刘立,迟国兴.68例苯磺酸左旋氨氯地平联合缬沙坦治疗原发性高血压的疗效观察[J].中国医药指南,2013,11(34):99-100. 被引量:12

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部